Franklin Resources Inc Agios Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 36,317 shares of AGIO stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,317

Previous 36,317 -0.0%

Holding current value

$1.28 Million

Previous $1.61 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$41.19 - $49.72 $1.5 Million - $1.81 Million	36,317 New	36,317 $1.61 Million
Q2 2023 Aug 11, 2023	BUY	$21.38 - $29.19 $876 - $1,196	41 Added 0.41%	10,021 $283,000
Q1 2023 May 12, 2023	SELL	$21.74 - $30.93 $2,021 - $2,876	-93 Reduced 0.92%	9,980 $229,000
Q4 2022 Feb 10, 2023	BUY	$24.81 - $31.52 $49,694 - $63,134	2,003 Added 24.82%	10,073 $282,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $157,445 - $275,509	8,070 New	8,070 $229,000
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $4.67 Million - $6.88 Million	-101,700 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$42.73 - $76.53 $1.89 Million - $3.39 Million	44,300 Added 77.18%	101,700 $4.69 Million
Q1 2018 May 10, 2018	SELL	$59.83 - $86.53 $305,133 - $441,303	-5,100 Reduced 8.16%	57,400 $4.69 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $130,300 - $180,825	-2,500 Reduced 3.85%	62,500 $3.57 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $3.57 Million - $4.36 Million	65,000	65,000 $4.34 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.93B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Agios Pharmaceuticals, Inc. Transaction History